The motto of OpenSpecimen is “biospecimens without highquality data are of no value.” Hence, the distinguishing feature of the free and open source bio-bank management database is that it collects and processes standards-based data specific to a disease or study requirements. Currently, more than 30 bio-banks spanning 13 countries are using OpenSpecimen.

WE TAKE YOU PLACES YOU'VE NEVER BEEN

The OpenSpecimen LIMS application allows bio-repositories to track biospecimens from collection to utilization across multiple projects, collect annotations, storage containers, track requests and distribution, and has multiple reporting options. It streamlines management across collection, consent, QC, request and distribution and is highly configurable and customizable. Krishagni actively develops newer versions, provides professional support and is working on internationalisation of the product, starting with Chinese and Spanish versions. Biobankers from across the globe acknowledged, at last year’s annual community meeting, that OpenSpecimen fulfils many critical needs of the biobanking industry. Bootstrapped and ‘will remain so’ “We are fully bootstrapped, and are not looking for funding unless a partner brings with him strategic value, in terms of industry expertise and network,” says Srikanth, who has not yet talked to any investors.

WE WILL SHOW YOU THINGS YOU HAVE NEVER SEEN

The OpenSpecimen LIMS application allows bio-repositories to track biospecimens from collection to utilization across multiple projects, collect annotations, storage containers, track requests and distribution, and has multiple reporting options. It streamlines management across collection, consent, QC, request and distribution and is highly configurable and customizable. Krishagni actively develops newer versions, provides professional support and is working on internationalisation of the product, starting with Chinese and Spanish versions. Biobankers from across the globe acknowledged, at last year’s annual community meeting, that OpenSpecimen fulfils many critical needs of the biobanking industry. Bootstrapped and ‘will remain so’ “We are fully bootstrapped, and are not looking for funding unless a partner brings with him strategic value, in terms of industry expertise and network,” says Srikanth, who has not yet talked to any investors.

MEET THE TEAM

Srikanth Adiga

Srikanth Adiga

CEO & Founder

Srikanth is involved in OpenSpecimen (formerly caTissue) since 2005. Since 2011, he is involved in development of OpenSpecimen with a focus to build a world class open source biobanking software.

 

 

Srikanth Adiga

Srikanth Adiga

CEO & Founder

Srikanth is involved in OpenSpecimen (formerly caTissue) since 2005. Since 2011, he is involved in development of OpenSpecimen with a focus to build a world class open source biobanking software.

 

 

Vinayak Pawar

Vinayak Pawar

CTO & Developer

Vinayak is the technical brain behind OpenSpecimen and key transforming OpenSpeicmen into a high performance, robust and scalable application using latest web technologies.

 

Vinayak Pawar

Vinayak Pawar

CTO & Developer

Vinayak is the technical brain behind OpenSpecimen and key transforming OpenSpeicmen into a high performance, robust and scalable application using latest web technologies.

 

Poornima Govindrao

Poornima Govindrao

Senior Business Analyst, Trainer

Poornima has been part of OpenSpecimen since 2006 & knows the product in and out. She has trained numerous centers to adopt OpenSpecimen and involved in requirements gathering and end user support.

Poornima Govindrao

Poornima Govindrao

Senior Business Analyst, Trainer

Poornima has been part of OpenSpecimen since 2006 & knows the product in and out. She has trained numerous centers to adopt OpenSpecimen and involved in requirements gathering and end user support.